会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Human parathyroid hormone modifications, preparation and use
    • 人甲状旁腺激素修饰,制备和使用
    • US20050203012A1
    • 2005-09-15
    • US10959605
    • 2004-10-07
    • F. Richard BringhurstHisashi TakasuThomas GardellaJohn Potts
    • F. Richard BringhurstHisashi TakasuThomas GardellaJohn Potts
    • C12N15/09A61K38/00A61P19/10C07K14/635C12N1/19C12N1/21C12N5/10C12N15/16C12P21/02A61K38/17
    • C07K14/635A61K38/00
    • Synthetic and/or recombinant biologically active peptide derivatives of PTH(1-28), comprising a biologically active peptide at least 90% identical to a peptide consisting essentially of the formula: (a)X01ValSerGluIleGlnLeuMetHisAsn(SEQ ID NO:1); LeuGlyLysHisLeuAsnSerMetX02Arg ValGluTrpLeuArgLysLysLeu (b) fragments thereof containing amino acids 1-24, 1-25, 1-26, or 1-27; (c) pharmaceutically acceptable salts thereof; or (d) N- or C-derivatives thereof; wherein: X01 is Ser, Ala or Gly; and X02 is Glu or Arg, provided that said peptide is not hPTH(1-26)NH2, hPTH(1-27)NH2 or hPTH(1-28)NH2.
    • PTH(1-28)的合成和/或重组生物活性肽衍生物,其包含与基本上由下式构成的肽至少90%相同的生物活性肽:
      < colspec colname =“1”colwidth =“14PT”align =“left”/> (a) X ValSerGluIleGlnLeuMetHisAsn (SEQ ID NO:1); LeuGlyLysHisLeuAsnSerMetX Arg ROW> ValGluTrpLeuArgLysLysLeu (b)其含有氨基酸1-24,1 -25,1-26或1-27; (c)其药学上可接受的盐; 或(d)其N-或C-衍生物; 其中:X 0,1是Ser,Ala或Gly; 如果所述肽不是hPTH(1-26)NH 2,hPTH(1-27)NH 2,则X O 2是Glu或Arg, 或HPTH(1-28)NH 2。
        • 6. 发明申请
        • Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
        • 构象约束甲状旁腺素(pth)类似物与内酰胺桥
        • US20060229240A1
        • 2006-10-12
        • US10542704
        • 2003-01-24
        • Thomas GardellaHenry KronenbergJohn Potts
        • Thomas GardellaHenry KronenbergJohn Potts
        • A61K38/16A61K38/10
        • C07K14/635A61K38/29
        • The present invention relates to methods of treatment of mammalian conditions characterized by decreases in bone mass with conformationally constrained parathyroid hormone (PTH) analogs and derivatives of those analogs containing PTH polypeptide derivatives containing at least one Glu or Lys substitution at position 6 and/or 10, some with installed lactam bridges between the side chains of Lys and Glu. The invention provides derivatives of PTH (1-34), PTH(1-33), PTH(1-32), PTH(1-31), PTH(1-30), PTH(1-29), PTH(1-28), PTH(1-27), PTH(1-26), PTH(1-25), PTH(1-24), PTH(1-23), PTH(1-22), PTH (1-21), PTH(1-20), PTH(1-19), PTH(1-18), PTH(1-17), PTH(1-16), PTH(1-15), PTH(1-14), PTH(1-13), PTH(1-12), PTH(1-11), PTH(1-10) and PTH(1-9) polypeptide. The invention also provides methods of preparing the PTH analogs. Further, the invention encompasses treating conditions that are characterized by undesired bone loss or by the need for bone growth, e.g. in treating fractures or cartilage disorders and for raising cAMP levels in cells where deemed necessary.
        • 本发明涉及治疗哺乳动物病症的方法,其特征在于具有构象约束的甲状旁腺激素(PTH)类似物的骨量减少和含有在第6位和/或第10位含有至少一个Glu或Lys取代的PTH多肽衍生物的那些类似物的衍生物 ,一些在Lys和Glu的侧链之间安装了内酰胺桥。 本发明提供了PTH(1-34),PTH(1-33),PTH(1-32),PTH(1-31),PTH(1-30),PTH(1-29),PTH -2TH),PTH(1-27),PTH(1-26),PTH(1-25),PTH(1-24),PTH(1-23),PTH(1-22) 21),PTH(1-20),PTH(1-19),PTH(1-18),PTH(1-17),PTH(1-16),PTH(1-15),PTH ),PTH(1-13),PTH(1-12),PTH(1-11),PTH(1-10)和PTH(1-9)多肽。 本发明还提供了制备PTH类似物的方法。 此外,本发明包括以不良骨丢失或骨生长需要为特征的治疗条件,例如。 在治疗骨折或软骨障碍并提高认为必要的细胞中的cAMP水平。
        • 8. 发明申请
        • Conformationally constrained parathyroid hormone (pth) analogs
        • 构象约束甲状旁腺激素(pth)类似物
        • US20050026839A1
        • 2005-02-03
        • US10484080
        • 2002-07-19
        • Thomas Gardella
        • Thomas Gardella
        • A61K38/00A61K49/00A61K51/00A61P5/18A61P5/20A61P19/08A61P19/10C07K14/635A61K38/10C07K7/08
        • C07K14/635A61K38/00
        • The present invention relates to conformationally constrained parathyroid hormone (PTH) analogs, and methods of preparing and using the PTH analogs. The invention provides novel PTH polypeptide derivatives containing amino acid substitutions at selected positions in the polypeptides. The invention provides derivatives of PTH (1-34), PTH(1-21), PTH(1-20), PTH(1-19), PTH(1-18), PTH(1-17), PTH(1-16), PTH(1-15), PTH(1-14), PTH(1-13), PTH(1-12), PTH(1-11) and PTH(1-1 0) polypeptides, wherein at least one residue in each polypeptide is a helix, preferably an a-helix, stabilizing residue. The invention also provides methods of making such peptides. Further, the invention encompasses compositions and methods for use in limiting undesired bone loss in a vertebrate at risk of such bone loss, in treating conditions that are characterized by undesired bone loss or by the need for bone growth, e.g. in treating fractures or cartilage disorders and for raising cAMP levels in cells where deemed necessary.
        • 本发明涉及构象约束的甲状旁腺激素(PTH)类似物,以及制备和使用PTH类似物的方法。 本发明提供了在多肽的选定位置含有氨基酸取代的新型PTH多肽衍生物。 本发明提供了PTH(1-34),PTH(1-21),PTH(1-20),PTH(1-19),PTH(1-18),PTH(1-17),PTH -16),PTH(1-15),PTH(1-14),PTH(1-13),PTH(1-12),PTH(1-11)和PTH(1-10)多肽,其中 每个多肽中的至少一个残基是螺旋,优选α-螺旋的稳定残基。 本发明还提供了制备这些肽的方法。 此外,本发明包括用于限制在具有这种骨丢失风险的脊椎动物中不期望的骨丢失的组合物和方法,在治疗以不期望的骨丢失为特征的病症中,或通过对骨生长的需要。 在治疗骨折或软骨障碍并提高认为必要的细胞中的cAMP水平。